Therapy for early reperfusion after stroke
Eric Juttler*, Martin Kohrmann and Peter D Schellinger
Correspondence *Department of Neurology, University of Heidelberg, Im Neuenheimer Feld 400, D–69120 Heidelberg, Germany
Email eric.juettler@med.uni-heidelberg.de
Currently, the only proven treatment to re-establish cerebral blood flow in acute ischemic stroke is intravenous tissue plasminogen activator within 3 h of symptom onset. Few patients, however, qualify for this therapy. Here, Juttler et al. provide an integrated view of the current state of reperfusion therapy in acute stroke patients and discuss future treatment options to extend the therapeutic window for intervention.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Thrombi?beware of red cells bearing giftsNature Biotechnology News and Views (01 Aug 2003)
tPA: A neuron buster, too?Nature Medicine News and Views (01 Feb 1998)
RESEARCH
Glycoprotein IIb/IIIa Antagonist, Murine 7E3 F(ab')2, and Tissue Plasminogen Activator in Focal Ischemia: Evaluation of Efficacy and Risk of Hemorrhage With Combination TherapyJournal of Cerebral Blood Flow & Metabolism Original Article
See all 37 matches for Research